Skip to main content
Erschienen in: Journal of Neurology 12/2010

01.12.2010 | Original Communication

Impairment of sensory-motor integration in patients affected by RLS

verfasst von: Vincenzo Rizzo, I. Aricò, G. Liotta, L. Ricciardi, C. Mastroeni, F. Morgante, R. Allegra, R. Condurso, P. Girlanda, R. Silvestri, A. Quartarone

Erschienen in: Journal of Neurology | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Much evidence suggests that restless legs syndrome (RLS) is a disorder characterized by an unsuppressed response to sensory urges due to abnormalities in inhibitory pathways that specifically link sensory input and motor output. Therefore, in the present study, we tested sensory-motor integration in patients with RLS, measured by short latency afferent inhibition (SAI) and long latency afferent inhibition (LAI). SAI and LAI were determined using transcranial magnetic stimulation before and after 1month of dopaminergic treatment in RLS patients. Ten naïve patients with idiopathic RLS and ten healthy age-matched controls were recruited. Patients with secondary causes for RLS (e.g. renal failure, anaemia, low iron and ferritin) were excluded, as well as those with other sleep disorders. Untreated RLS patients demonstrated deficient SAI in the human motor cortex, which proved revertible toward normal values after dopaminergic treatment. We demonstrated an alteration of sensory-motor integration, which is normalized by dopaminergic treatment, in patients affected by RLS. It is likely that the reduction of SAI might contribute significantly to the release of the involuntary movements and might account for the sensory urge typical of this condition.
Literatur
1.
Zurück zum Zitat Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165:1286–1292CrossRefPubMed Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165:1286–1292CrossRefPubMed
2.
Zurück zum Zitat Hening W (2004) The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization. Clin Neurophysiol 115:1965–1974CrossRefPubMed Hening W (2004) The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization. Clin Neurophysiol 115:1965–1974CrossRefPubMed
3.
Zurück zum Zitat Mosko SS, Nudleman KL (1986) Somatosensory and brainstem auditory evoked responses in sleep-related periodic leg movements. Sleep 9:399–404PubMed Mosko SS, Nudleman KL (1986) Somatosensory and brainstem auditory evoked responses in sleep-related periodic leg movements. Sleep 9:399–404PubMed
4.
Zurück zum Zitat Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C (1997) Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 41:639–645CrossRefPubMed Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C (1997) Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 41:639–645CrossRefPubMed
5.
Zurück zum Zitat Tyvaert L, Houdayer E, Devanne H, Bourriez JL, Derambure P, Monaca C (2009) Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. Sleep Med 10(10):1090–1096CrossRefPubMed Tyvaert L, Houdayer E, Devanne H, Bourriez JL, Derambure P, Monaca C (2009) Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. Sleep Med 10(10):1090–1096CrossRefPubMed
6.
Zurück zum Zitat Entezari-Taher M, Singleton JR, Jones CR, Meekins G, Petajan JH, Smith AG (1999) Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 53:1201–1205PubMed Entezari-Taher M, Singleton JR, Jones CR, Meekins G, Petajan JH, Smith AG (1999) Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 53:1201–1205PubMed
7.
Zurück zum Zitat Tergau F, Wischer S, Paulus W (1999) Motor system excitability in patients with restless legs syndrome. Neurology 52:1060–1063PubMed Tergau F, Wischer S, Paulus W (1999) Motor system excitability in patients with restless legs syndrome. Neurology 52:1060–1063PubMed
8.
Zurück zum Zitat Quatrale R, Manconi M, Gastaldo E, Eleopra R, Tugnoli V, Tola MR, Granieri E (2003) Neurophysiological study of corticomotor pathways in restless legs syndrome. Clin Neurophysiol 114:1638–1645CrossRefPubMed Quatrale R, Manconi M, Gastaldo E, Eleopra R, Tugnoli V, Tola MR, Granieri E (2003) Neurophysiological study of corticomotor pathways in restless legs syndrome. Clin Neurophysiol 114:1638–1645CrossRefPubMed
9.
Zurück zum Zitat Scalise A, Cadore IP, Gigli GL (2004) Motor cortex excitability in restless legs syndrome. Sleep Med 5:393–396CrossRefPubMed Scalise A, Cadore IP, Gigli GL (2004) Motor cortex excitability in restless legs syndrome. Sleep Med 5:393–396CrossRefPubMed
10.
Zurück zum Zitat Nardone R, Ausserer H, Bratti A, Covi M, Lochner P, Marth R, Tezzon F (2006) Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Acta Neurol Scand 114:244–249CrossRefPubMed Nardone R, Ausserer H, Bratti A, Covi M, Lochner P, Marth R, Tezzon F (2006) Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Acta Neurol Scand 114:244–249CrossRefPubMed
11.
Zurück zum Zitat Gorsler A, Liepert J (2007) Influence of cabergoline on motor excitability in patients with restless legs syndrome. J Clin Neurophysiol 24:456–460CrossRefPubMed Gorsler A, Liepert J (2007) Influence of cabergoline on motor excitability in patients with restless legs syndrome. J Clin Neurophysiol 24:456–460CrossRefPubMed
12.
Zurück zum Zitat Scalise A, Pittaro-Cadore I, Janes F, Marinig R, Gigli GL (2010) Changes of cortical excitability after dopaminergic treatment in restless legs syndrome. Sleep Med 11(1):75–81CrossRefPubMed Scalise A, Pittaro-Cadore I, Janes F, Marinig R, Gigli GL (2010) Changes of cortical excitability after dopaminergic treatment in restless legs syndrome. Sleep Med 11(1):75–81CrossRefPubMed
13.
Zurück zum Zitat Comella CL (2002) Restless legs syndrome: treatment with dopaminergic agents. Neurology 58:S87–S92PubMed Comella CL (2002) Restless legs syndrome: treatment with dopaminergic agents. Neurology 58:S87–S92PubMed
14.
Zurück zum Zitat Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523(Pt 2):503–513CrossRefPubMed Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523(Pt 2):503–513CrossRefPubMed
15.
Zurück zum Zitat Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113CrossRefPubMed Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113CrossRefPubMed
16.
Zurück zum Zitat Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10:634–642CrossRefPubMed Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10:634–642CrossRefPubMed
17.
Zurück zum Zitat Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119CrossRefPubMed Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119CrossRefPubMed
18.
Zurück zum Zitat Iber C, Ancoli-Israel S, Chesson A, and Quan SF for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Iber C, Ancoli-Israel S, Chesson A, and Quan SF for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications.
19.
Zurück zum Zitat Sale MV, Ridding MC, Nordstrom MA (2007) Factors influencing the magnitude and reproducibility of corticomotor excitability changes induced by paired associative stimulation. Exp Brain Res 181:615–626CrossRefPubMed Sale MV, Ridding MC, Nordstrom MA (2007) Factors influencing the magnitude and reproducibility of corticomotor excitability changes induced by paired associative stimulation. Exp Brain Res 181:615–626CrossRefPubMed
20.
Zurück zum Zitat Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519PubMed Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519PubMed
21.
Zurück zum Zitat Kutukcu Y, Dogruer E, Yetkin S, Ozgen F, Vural O, Aydin H (2006) Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome. Muscle Nerve 33:133–137CrossRefPubMed Kutukcu Y, Dogruer E, Yetkin S, Ozgen F, Vural O, Aydin H (2006) Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome. Muscle Nerve 33:133–137CrossRefPubMed
22.
Zurück zum Zitat Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996) The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109:127–135CrossRefPubMed Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996) The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109:127–135CrossRefPubMed
23.
Zurück zum Zitat Hanajima R, Ugawa Y, Terao Y, Ogata K, Kanazawa I (1996) Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J Neurol Sci 140:109–116CrossRefPubMed Hanajima R, Ugawa Y, Terao Y, Ogata K, Kanazawa I (1996) Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J Neurol Sci 140:109–116CrossRefPubMed
24.
Zurück zum Zitat Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W (1997) Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 105:430–437CrossRefPubMed Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W (1997) Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 105:430–437CrossRefPubMed
25.
Zurück zum Zitat Sanger TD, Garg RR, Chen R (2001) Interactions between two different inhibitory systems in the human motor cortex. J Physiol 530:307–317CrossRefPubMed Sanger TD, Garg RR, Chen R (2001) Interactions between two different inhibitory systems in the human motor cortex. J Physiol 530:307–317CrossRefPubMed
26.
Zurück zum Zitat Abbruzzese G, Marchese R, Buccolieri A, Gasparetto B, Trompetto C (2001) Abnormalities of sensorimotor integration in focal dystonia: a transcranial magnetic stimulation study. Brain 124:537–545CrossRefPubMed Abbruzzese G, Marchese R, Buccolieri A, Gasparetto B, Trompetto C (2001) Abnormalities of sensorimotor integration in focal dystonia: a transcranial magnetic stimulation study. Brain 124:537–545CrossRefPubMed
27.
Zurück zum Zitat Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC (2000) Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135:455–461CrossRefPubMed Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC (2000) Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135:455–461CrossRefPubMed
28.
Zurück zum Zitat Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P (2005) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661–668CrossRefPubMed Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P (2005) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661–668CrossRefPubMed
29.
Zurück zum Zitat Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2004) Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:555–559CrossRefPubMed Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2004) Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:555–559CrossRefPubMed
30.
31.
Zurück zum Zitat Lidsky TI, Manetto C, Schneider JS (1985) A consideration of sensory factors involved in motor functions of the basal ganglia. Brain Res 356:133–146PubMed Lidsky TI, Manetto C, Schneider JS (1985) A consideration of sensory factors involved in motor functions of the basal ganglia. Brain Res 356:133–146PubMed
32.
Zurück zum Zitat Turjanski N, Lees AJ, Brooks DJ (1999) Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52:932–937PubMed Turjanski N, Lees AJ, Brooks DJ (1999) Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52:932–937PubMed
33.
Zurück zum Zitat Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, Lai RY, Halldin C, Farde L (2006) Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 129:2017–2028CrossRefPubMed Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, Lai RY, Halldin C, Farde L (2006) Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 129:2017–2028CrossRefPubMed
34.
Zurück zum Zitat Thierry AM, Blanc G, Sobel A, Stinus L, Golwinski J (1973) Dopaminergic terminals in the rat cortex. Science 182:499–501CrossRefPubMed Thierry AM, Blanc G, Sobel A, Stinus L, Golwinski J (1973) Dopaminergic terminals in the rat cortex. Science 182:499–501CrossRefPubMed
35.
Zurück zum Zitat Gaspar P, Stepniewska I, Kaas JH (1992) Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J Comp Neurol 325:1–21CrossRefPubMed Gaspar P, Stepniewska I, Kaas JH (1992) Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J Comp Neurol 325:1–21CrossRefPubMed
36.
Zurück zum Zitat Huda K, Matsunami K (2003) Influence of dopamine on ventrolateral thalamic inputs in cat motor cortex. Brain Res 963:178–189CrossRefPubMed Huda K, Matsunami K (2003) Influence of dopamine on ventrolateral thalamic inputs in cat motor cortex. Brain Res 963:178–189CrossRefPubMed
37.
Zurück zum Zitat Sailer A, Cunic DI, Paradiso GO, Gunraj CA, Wagle-Shukla A, Moro E, Lozano AM, Lang AE, Chen R (2007) Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology 68:356–363CrossRefPubMed Sailer A, Cunic DI, Paradiso GO, Gunraj CA, Wagle-Shukla A, Moro E, Lozano AM, Lang AE, Chen R (2007) Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology 68:356–363CrossRefPubMed
Metadaten
Titel
Impairment of sensory-motor integration in patients affected by RLS
verfasst von
Vincenzo Rizzo
I. Aricò
G. Liotta
L. Ricciardi
C. Mastroeni
F. Morgante
R. Allegra
R. Condurso
P. Girlanda
R. Silvestri
A. Quartarone
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 12/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5644-y

Weitere Artikel der Ausgabe 12/2010

Journal of Neurology 12/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.